Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program
2023 · Lung Cancer · 18 citations
https://doi.org/10.1016/j.lungcan.2023.107444
E
Edoardo Garbo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
192
Citations
9
h-index
9
i10-index
Edoardo Garbo is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 9, co-authored 60 publications.
ORCID: 0000-0003-2394-9895Papers by this author
worksLung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
2024 · Annals of Oncology · 15 citations
https://doi.org/10.1016/j.annonc.2024.11.014
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
2025 · Journal for ImmunoTherapy of Cancer · 15 citations
https://doi.org/10.1136/jitc-2024-010674
First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC
2025 · Clinical Cancer Research · 4 citations
https://doi.org/10.1158/1078-0432.ccr-25-1735
P3.12C.02 MET Fusions in NSCLC: Prevalence, Oncogenicity, and Resistance Mechanism
2024 · Journal of Thoracic Oncology · 1 citations
https://doi.org/10.1016/j.jtho.2024.09.616
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity
2025 · Lung Cancer · 1 citations
https://doi.org/10.1016/j.lungcan.2025.108799
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat